91 related articles for article (PubMed ID: 12473804)
1. An evidence based approach to testing for antibody to herpes simplex virus type 2.
Copas AJ; Cowan FM; Cunningham AL; Mindel A
Sex Transm Infect; 2002 Dec; 78(6):430-4. PubMed ID: 12473804
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic.
Golden MR; Ashley-Morrow R; Swenson P; Hogrefe WR; Handsfield HH; Wald A
Sex Transm Dis; 2005 Dec; 32(12):771-7. PubMed ID: 16314775
[TBL] [Abstract][Full Text] [Related]
3. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection.
Cowan FM; Johnson AM; Ashley R; Corey L; Mindel A
J Infect Dis; 1996 Sep; 174(3):470-5. PubMed ID: 8769602
[TBL] [Abstract][Full Text] [Related]
4. False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands.
van Rooijen MS; Roest W; Hansen G; Kwa D; de Vries HJ
Sex Transm Infect; 2016 Jun; 92(4):257-60. PubMed ID: 26755775
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors.
van de Laar MJ; Termorshuizen F; Slomka MJ; van Doornum GJ; Ossewaarde JM; Brown DW; Coutinho RA; van den Hoek JA
Int J Epidemiol; 1998 Feb; 27(1):127-34. PubMed ID: 9563706
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial.
Gorfinkel IS; Aoki F; McNeil S; Dionne M; Shafran SD; Zickler P; Halperin S; Langley J; Bellamy A; Schulte J; Heineman T; Belshe R
Int J STD AIDS; 2013 May; 24(5):345-9. PubMed ID: 23970700
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
[TBL] [Abstract][Full Text] [Related]
8. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
Morrow RA; Friedrich D; Meier A; Corey L
BMC Infect Dis; 2005 Oct; 5():84. PubMed ID: 16225691
[TBL] [Abstract][Full Text] [Related]
9. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations.
Cowan FM; Johnson AM; Ashley R; Corey L; Mindel A
BMJ; 1994 Nov; 309(6965):1325-9. PubMed ID: 7866079
[TBL] [Abstract][Full Text] [Related]
10. Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.
Görander S; Mbwana J; Lyamuya E; Lagergård T; Liljeqvist JA
Clin Vaccine Immunol; 2006 Jun; 13(6):633-9. PubMed ID: 16760320
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults.
Zimet GD; Rosenthal SL; Fortenberry JD; Brady RC; Tu W; Wu J; Bernstein DI; Stanberry LR; Stone KM; Leichliter JS; Fife KH
Sex Transm Dis; 2004 Nov; 31(11):665-9. PubMed ID: 15502674
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy.
Suligoi B; Calistri A; Cusini M; Palù G;
J Med Virol; 2002 Jul; 67(3):345-8. PubMed ID: 12116025
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex type 2 infection in a cohort aged 21 years.
Eberhart-Phillips J; Dickson NP; Paul C; Fawcett JP; Holland D; Taylor J; Cunningham AL
Sex Transm Infect; 1998 Jun; 74(3):216-8. PubMed ID: 9849560
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence?
Cowan FM; Copas A; Johnson AM; Ashley R; Corey L; Mindel A
Sex Transm Infect; 2002 Oct; 78(5):346-8. PubMed ID: 12407237
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 2 infection of heterosexual men attending a sexual health centre.
Bassett I; Donovan B; Bodsworth NJ; Field PR; Ho DW; Jeansson S; Cunningham AL
Med J Aust; 1994 Jun; 160(11):697-700. PubMed ID: 8202004
[TBL] [Abstract][Full Text] [Related]
16. Performance of four diagnostic assays for detecting herpes simplex virus type 2 antibodies in the Middle East and North Africa.
Nasrallah GK; Dargham SR; Sahara AS; Elsidiq MS; Abu-Raddad LJ
J Clin Virol; 2019 Feb; 111():33-38. PubMed ID: 30639845
[TBL] [Abstract][Full Text] [Related]
17. Serologic herpes testing in the real world: validation of new type-specific serologic herpes simplex virus tests in a public health laboratory.
Turner KR; Wong EH; Kent CK; Klausner JD
Sex Transm Dis; 2002 Jul; 29(7):422-5. PubMed ID: 12170133
[TBL] [Abstract][Full Text] [Related]
18. Performance of ELISA and Western blot to detect antibodies against HSV-2 using dried blood spots.
García-Cisneros S; Sánchez-Alemán MÁ; Conde-Glez CJ; Lara-Zaragoza SJ; Herrera-Ortiz A; Plett-Torres T; Olamendi-Portugal M
J Infect Public Health; 2019; 12(2):224-228. PubMed ID: 30389368
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro Tanzania.
Mmbaga EJ; Leyna GH; Stray-Pedersen B; Klepp KI
East Afr J Public Health; 2011 Mar; 8(1):28-32. PubMed ID: 22066279
[TBL] [Abstract][Full Text] [Related]
20. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania.
Obasi A; Mosha F; Quigley M; Sekirassa Z; Gibbs T; Munguti K; Todd J; Grosskurth H; Mayaud P; Changalucha J; Brown D; Mabey D; Hayes R
J Infect Dis; 1999 Jan; 179(1):16-24. PubMed ID: 9841817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
